At a glance
CPH Group
Business in 2025
- First full financial year of CPH Group without the spun-off Paper Division
- Strategic acquisitions strengthen the market positions of Zeochem and Perlen Packaging
- Zeochem increases EBITDA margin to over 20 %
- Geopolitical tensions and economic developments, currency effects, and volume and margin pressure at Perlen Packaging slow business development
Portrait
CPH Group is a leading global industrial company focused on international growth markets. Headquartered in Switzerland, its activities are divided into two industrial divisions comprising the research, development, production and distribution of specialty chemicals and pharmaceutical packaging. The listed company operates 13 manufacturing locations in ten countries in Europe, Asia, North and South America, with an industrial tradition dating back more than 200 years.
Zeochem
Business in 2025
- Positive financial year despite challenging market conditions
- Further growth in deuterated products, CAGR 2021–2025: +21 %
- EBITDA hits new high
- Demand for molecular sieves damped
- High-quality chromatography gels added to the portfolio through acquisition of SiliCycle
Portrait
Zeochem is a leading global provider of specialty chemicals. It manufactures molecular sieves for industrial and medical applications, high-quality chromatography gels for the pharmaceutical industry, and deuterated products for analytics, pharmaceuticals and OLED displays. Zeochem operates production facilities in Switzerland, Bosnia-Herzegovina, the USA and Canada, as well as in China and India.
Perlen Packaging
Business in 2025
- Strengthening of market position and product portfolio through acquisition of LOG Pharma
- Sales up on previous year with acquisition
- Difficult market environment and new capacities in the pharmaceutical blister packaging market impacts EBITDA
- Measures taken to secure profitability
Portrait
Perlen Packaging is geared toward the pharmaceutical industry and is one of the top three suppliers of coated plastic films worldwide. The products manufactured at sites in Switzerland, Germany, China, Brazil and the USA are primarily used in blister packaging to protect medications. LOG Pharma, acquired in the reporting year, additionally operates in Israel and Hungary, where it produces packaging solutions such as vials and containers, likewise for medical use.